FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

29,056 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 25000 - 25200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.cdc.phinvadsR42.16.840.1.114222.4.11.984Dwelling Typeactive2008-01ussct oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3081Fetal Neonatal Infection Type (FDD)active2008-01ussct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3091Maternal Infection (FDD)active2008-01ussct tho oid
hl7.terminologyR5v3-ActInvoiceElementCodeActInvoiceElementCodeactive2014-03uvhl7tho
hl7.terminologyR5v3-ActInvoiceGroupCodeActInvoiceGroupCodeactive2014-03uvhl7tho
hl7.terminologyR5v3-ActInvoiceRootGroupCodeActInvoiceRootGroupCodeactive2014-03uvhl7tho
hl7.terminologyR5v3-ActInvoiceInterGroupCodeActInvoiceInterGroupCodeactive2014-03uvhl7tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3136PCR Performed Lab Location (VPD)active2008-01usoid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3139Serology Performed Lab Location (Pertussis)active2008-01usoid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7330Performing Laboratory Type (VPD)active2020-01ustho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3159Reporting Lab Typeactive2008-01ustho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7493Performing Lab Type (Arbovirus)active2016-01usoid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3090Lettuce Type (FDD)active2018-01ussct tho oid
hl7.fhir.us.davinci-vbprR4lobLine of Business Value Settrial-use1cqi2025-07ushl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.7949Treatment Type (COVID-19)active2020-01ussct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7997Treatment Type (Anthrax)active2020-01ussct tho
ca.on.ehr.r4R4ValueSet-DispenseCategoryDispense Category EHRactive2025-04canational
us.cdc.phinvadsR42.16.840.1.114222.4.11.3160Microscopic Exam Type (TB)active2008-01ussct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7196Non Treponemal Serologic Test (STD)active2020-01usoid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.3093Non Pork Type (FDD)active2008-01ustho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3095Outbreak Type (FDD)active2008-01ussct tho oid
hl7.fhir.us.davinci-vbprR4vbp-payment-streamPayment Stream Value Settrial-use1cqi2025-07ushl7fhir
hl7.fhir.us.davinci-drug-formularyR4PlanContactTypeVSType of plan contacttrial-usephx2025-02ushl7fhir tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3096Pork Type (FDD)active2008-01ussct tho oid
ca.on.ppr.r4R4ProviderOrganizationRoleType-providerProviderOrganizationRoleTypedrafthl7
ca.on.phsd.r4-alphaR4ProviderOrganizationRoleType-providerProviderOrganizationRoleTypedraft
ca.on.ppr.r4R4ProviderRoleClassType-providerProviderRoleClassTypedrafthl7
ca.on.phsd.r4-alphaR4ProviderRoleClassType-providerProviderRoleClassTypedraft
ca.on.ppr.r4R4ProviderAddressPurpose-providerProviderAddressPurposedrafthl7
ca.on.phsd.r4-alphaR4ProviderAddressPurpose-providerProviderAddressPurposedraft
us.cdc.phinvadsR42.16.840.1.114222.4.11.3100Seafood Type (FDD)active2018-01usoid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7692Rehab Type (RIBD)active2018-01ussct
hl7.terminologyR5artifact-relationship-typeArtifact Relationship Typeactivesd2025-02uvhl7tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7939Residence Type (COVID-19)active2020-01ussct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.825Referral Disposition (HL7)active2008-01ustho
ca.on.ppr.r4R4RestrictionToPracticeType-providerRestrictionToPracticeTypedrafthl7
ca.on.phsd.r4-alphaR4RestrictionToPracticeType-providerRestrictionToPracticeTypedraft
us.cdc.phinvadsR42.16.840.1.114222.4.11.7748Epidemiological Risk Factors (TB)active2019-01ussct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7708Rupture Type (RIBD)active2018-01ussct
hl7.terminologyR5v3-SecurityTrustFrameworkObservationTypeSecurityTrustFrameworkObservationTypeactive2014-08uvhl7tho
hl7.terminologyR5v3-SecurityTrustMechanismObservationTypeSecurityTrustMechanismObservationTypeactive2014-08uvhl7tho
hl7.terminologyR5v3-SecurityTrustCertificateObservationTypeSecurityTrustCertificateObservationTypeactive2014-08uvhl7tho
hl7.terminologyR5v3-SecurityObservationTypeSecurityObservationTypeactive2023-06uvhl7tho
hl7.terminologyR5v3-SecurityTrustObservationTypeSecurityTrustObservationTypeactive2023-06uvhl7tho
hl7.terminologyR5v3-SecurityTrustAgreementObservationTypeSecurityTrustAgreementObservationTypeactive2014-08uvhl7tho
hl7.terminologyR5v3-SecurityTrustAgreementObservationValueSecurityTrustAgreementObservationValueactive2014-08uvhl7tho
hl7.terminologyR5v3-SecurityCategoryObservationTypeSecurityCategoryObservationTypeactive2014-03uvhl7tho
hl7.terminologyR5v3-SecurityClassificationObservationTypeSecurityClassificationObservationTypeactive2014-03uvhl7tho
hl7.terminologyR5v3-SecurityControlObservationTypeSecurityControlObservationTypeactive2014-03uvhl7tho
hl7.terminologyR5v3-SecurityDataIntegrityObservationTypeSecurityDataIntegrityObservationTypeactive2014-03uvhl7tho
hl7.terminologyR5v3-SecurityDataIntegrityObservationValueSecurityDataIntegrityObservationValueactive2024-02uvhl7tho
hl7.terminologyR5v3-SecurityTrustAccreditationObservationTypeSecurityTrustAccreditationObservationTypeactive2014-08uvhl7tho
hl7.terminologyR5v3-SecurityIntegrityConfidenceObservationTypeSecurityIntegrityConfidenceObservationTypeactive2014-03uvhl7tho
hl7.terminologyR5v3-SecurityIntegrityObservationTypeSecurityIntegrityObservationTypeactive2014-03uvhl7tho
hl7.terminologyR5v3-SecurityIntegrityObservationValueSecurityIntegrityObservationValueactive2024-02uvhl7tho
hl7.terminologyR5v3-SecurityIntegrityProvenanceAssertedByObservationTypeSecurityIntegrityProvenanceAssertedByObservationTypeactive2019-03uvhl7tho
hl7.terminologyR5v3-SecurityIntegrityProvenanceReportedByObservationTypeSecurityIntegrityProvenanceReportedByObservationTypeactive2019-03uvhl7tho
hl7.terminologyR5v3-SecurityIntegrityStatusObservationTypeSecurityIntegrityStatusObservationTypeactive2014-03uvhl7tho
hl7.terminologyR5v3-SecurityIntegrityProvenanceObservationTypeSecurityIntegrityProvenanceObservationTypeactive2014-03uvhl7tho
hl7.terminologyR5v3-SecurityIntegrityProvenanceObservationValueSecurityIntegrityProvenanceObservationValueactive2024-02uvhl7tho
dk.fhir.ig.kl.common.caresocialR4KLRequestFromFSIIIKLRequestFromFSIIIactive2020-10
kl.dk.fhir.termR4KLRequestFromFSIIIKLHenvendelseHenvisningFraFSIIIactive2024-10dkoid
kl.dk.fhir.coreR4KLRequestFromFSIIIKLHenvendelseHenvisningFraFSIIIactive2023-06dk
ca.on.ppr.r4R4ServiceType-THLNService Type-THLNdraft
ca.on.phsd.r4-alphaR4ServiceType-OCEANService Type OCEANdraftsct
ca.on.phsd.r4-alphaR4ServiceType-THLNService Type-THLNdraft
ng.gov.nphcda.immunizationR4nigeria-session-typeNG-Imm Session Type VSactive2025-08internal
us.cdc.phinvadsR42.16.840.1.114222.4.11.7998Severe Weather Type (Leptospirosis)active2020-01ussct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7683Substance Abuse (RIBD)active2019-01ussct tho oid
MyHIE.v4-testR4value-set-task-code-my-coreValueSetTaskCode (MY Core)active2023-03
IdHIE.0vR4value-set-task-code-id-coreValueSetTaskCode (ID Core)active2023-06
us.cdc.phinvadsR42.16.840.1.114222.4.11.7329Type of Testing at CDC (NND)active2020-01ussct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3143Tetanus Type (VPD)active2008-01ussct tho
nictiz.fhir.nl.stu3.zib2015R32.16.840.1.113883.2.4.3.11.60.103.11.2--20111012000000JournaalregelTyperetirednl
hl7.terminologyR5verificationresult-primary-source-typePrimary-source-typeactive1pa2024-04uvhl7tho
hl7.fhir.us.mdiR4vs-tracking-number-typeTracking Number Typetrial-use3pher2025-07ushl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.7197Treponemal Serologic Test (STD)active2020-01usoid loinc
signal.core.r4R4questionnaire-ccars-type-of-updateQuestionnaire CCARS Type Of Updatedraft1paushl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.7335Vaccine Administered (Pertussis)active2020-01uscvx tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7448Vaccine Type (NND)active2022-01uscvx tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7688Vaccine Type (RIBD)active2018-01uscvx tho oid
hl7.fhir.us.davinci-raR4cc-typeCondition Category Typetrial-use2cqi2025-07ushl7fhir
hl7.fhir.us.davinci-vbprR4vbp-performance-metricPerformance Metrictrial-use1cqi2025-07ushl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.3254Employment Status (Flu)active2009-01ussct tho
nictiz.fhir.nl.stu3.geboortezorgR32.16.840.1.113883.2.4.3.11.60.90.77.11.18--20140814143051Type operatieactivenlfhir sct
nictiz.fhir.nl.stu3.geboortezorgR32.16.840.1.113883.2.4.3.11.60.90.77.11.19--20140814144207Type stollingsprobleemactivenlfhir sct
ans.fr.nosR4JDV-J36-TypeTarif-RORJDV_J36-TypeTarif-RORactive2023-06frnational
nictiz.fhir.nl.stu3.geboortezorgR32.16.840.1.113883.2.4.11.221--20161201112008Type verwijzingactivenlfhir sct
nictiz.fhir.nl.stu3.geboortezorgR32.16.840.1.113883.2.4.3.11.60.90.77.11.21--20160108110123Type vrouwelijke genitale verminkingactivenlfhir sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.3314Specimen Type (Malaria)active2017-01ussct tho oid
de.medizininformatikinitiative.kerndatensatz.laborbefundR4mii-vs-labor-identifier-type-codesMII VS Labor Identifier Type Codesactivedefhir tho
healthdata.be.r4.cbbR4TypeOfDisorderTypeOfDisorderdraftsct tho
healthdata.be.r4.cbbR4TypeOfDrugOrMedicationTypeOfDrugOrMedicationdraftsct
healthdata.be.r4.cbbR4TypeOfHelpTypeOfHelpdraftsct
healthdata.be.r4.cbbR4TypeOfHomeTypeOfHomedraftsct
healthdata.be.r4.cbbR4TypeOfInterventionTypeOfInterventiondraftsct
healthdata.be.r4.cbbR4TypeOfLivingWillTypeOfLivingWilldraftsct
healthdata.be.r4.cbbR4TypeOfSmokingOrTobaccoTypeOfSmokingOrTobaccodraftsct
nictiz.fhir.nl.stu3.geboortezorgR32.16.840.1.113883.2.4.11.182--20161122140045TypePartusactivenlfhir sct oid
nictiz.fhir.nl.stu3.geboortezorgR32.16.840.1.113883.2.4.11.182--20200811153819TypePartusactivenlfhir sct
nictiz.fhir.nl.stu3.geboortezorgR32.16.840.1.113883.2.4.11.348--20211101122336TypeVerwijzing_3.2activenlsct
dk.kip.rkkp.fhir.ig.coreR4PTNMtypepTNM typeactive2022-06internal
dk.kip.rkkp.fhir.ig.coreR4CentralBlockTypeTyper af central blokadeactive2022-06internal
dk.kip.rkkp.fhir.ig.coreR4KomplikationerVaskulaerDMPNKomplikationer Vaskulær DMPNactive2022-07internal
dk.kip.rkkp.fhir.ig.coreR4SymptomerMikrovaskulaerSymptomer Mikrovaskulæreactive2022-07internal
dk.kip.rkkp.fhir.ig.coreR4NerveBlockTypeUpperTyper af blokade overekstremiteteractive2022-06internal
dk.kip.rkkp.fhir.ig.coreR4NerveBlockTypeLowerTyper af blokade underekstremiteteractive2022-06internal
poc.bonsai.currentR4end-operation-typesOperationstyper i $enddraft2024-06fhir
ans.fr.nosR4JDV-J96-TypeActiviteLiberale-RASSJDV_J96-TypeActiviteLiberale-RASSactive2020-04frnational
ans.fr.nosR4JDV-J171-TypeAutorisation-EPARSJDV_J171-TypeAutorisation-EPARSactive2025-01frnational
ans.fr.nosR4JDV-J197-XdsTypesIdentifiantsReferenceId-CISISJDV_J197-XdsTypesIdentifiantsReferenceId-CISISactive2022-06frnational
ans.fr.nosR4JDV-J231-XdsTypesIdentifiantsReferenceId-DMPJDV_J231-XdsTypesIdentifiantsReferenceId-DMPactive2022-12frnational
ans.fr.nosR4JDV-J236-TypeIdentifiant-RORJDV_J236-TypeIdentifiant-RORactive2023-10frnational
ans.fr.nosR4JDV-J81-TypeDiplome-RASSJDV_J81-TypeDiplome-RASSactive2023-05frnational
ans.fr.nosR4JDV-J91-TypeSavoirFaire-RASSJDV_J91-TypeSavoirFaire-RASSactive2024-03frnational
de.gematik.epaR4epa-auditevent-type-vsEPA AuditEvent Typeactive2025-05detho dcm
hl7.eu.fhir.pcspR4vs-brachytherapyType-eu-pcspBrachytherapy Typedraft2025-08euhl7internal
us.cdc.phinvadsR42.16.840.1.114222.4.11.7977Brucella Exposure (Brucellosis)active2021-01ussct tho
ForgePatientChart.0830R4telus-contactpoint-systemTELUS ValueSet - Contact Point Systemdraft2020-11hl7fhir
ForgePatientChart.0830R4telus-contactpoint-useTELUS ValueSet - Contact Point Usedraft2020-11hl7fhir
hl7.fhir.us.pacio-adiR4ADIDocumentationTypeVSDocumentation Typestrial-use2pe2025-08ushl7sct loinc
hl7.eu.fhir.pcspR4vs-gastrostomyProcedureType-eu-pcspGastrostomy Surgical Procedure Typedraft2025-08euhl7sct
hl7.terminologyR5v3-MaterialEntityClassTypeMaterialEntityClassTypeactive2014-03uvhl7tho
au.digitalhealth.cda.schemaR5CDAMaterialEntityClassTypeCDAMaterialEntityClassTypedraft12025-08aunationaltho
signal.core.r4R4signal-organization-typeSignal Organization Typedraft2023-07ushl7tho
hl7.fhir.us.Davinci-drug-formularyR4usdf-PharmacyTypeVSPharmacy Type VSdraft2020-01ushl7fhir
hl7.eu.fhir.pcspR4vs-ProsthesisType-eu-pcspProsthesis Typedraft2025-08euhl7internal tho
hl7.eu.fhir.pcspR4vs-ProstheticProcedureType-eu-pcspProsthetic Surgical Procedure Typedraft2025-08euhl7sct
hl7.fhir.us.vdorR4vdor-types-of-treatment-for-substance-use-disorder-vsVDOR Types of Treatment for Substance Use Disorderinformativepher2025-06ushl7fhir
hl7.terminologyR5v2-0301hl7VS-universalIdTypeactive2019-12uvhl7tho
hl7.eu.fhir.idea4rcR4obsYesNo-code-eu-i4rcTypes of Yes/No observationsactive2025-07euhl7internal
tewhatuora.hip-coreR4nhi-address-typeNHI Address Type Codesactive2024-10nationalfhir
hl7.eu.fhir.pcspR4vs-amputationProcedureType-eu-pcspAmputation Surgical Procedure Typedraft2025-08euhl7sct
hl7.fhir.uv.lab-reportR4speciesType-uv-labTypes of speciesdraft1oo2025-01uvhl7sct
hl7.fhir.eu.laboratoryR4lab-speciesType-eu-vsTypes of speciesdraft12025-07euhl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.3121Birth Attendees (VPD)active2008-01ussct tho oid
dhpR5benefits-vsTypes of benefitsdraft2025-07internal
uz.dhp.coreR5benefits-vsTypes of benefitsdraft2025-08internal
hl7.fhir.us.mcodeR4mcode-benign-uncertain-neoplasm-brain-cns-disorder-vsBenign Neoplasm of Brain and CNS Disorder Value Setactive4cic2025-02ushl7sct icd
hl7.fhir.uv.ebmR6181524Risk Of Bias Type Value Setactive2025-08uvhl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.3058Cancer Typeactive2008-01ussct
hl7.fhir.us.mcodeR4mcode-carcinoma-in-situ-disorder-vsCarcinoma In-Situ Disorder Value Setactive4cic2025-02ushl7sct icd
hl7.fhir.us.davinci-pasR4PASCommunicationRequestMediumPAS Communication Medium Value Settrial-use3fm2025-07ushl7fhir x12
uz.dhp.coreR5clinical-status-vsTypes of clinical statusdraft2025-08tho
hl7.eu.fhir.pcspR4vs-colostomyProcedureType-eu-pcspColostomy Surgical Procedure Typedraft2025-08euhl7sct
hl7.terminologyR5synthesis-typeStatisticSynthesisTypedraft0cds2020-02uvhl7tho
hl7.terminologyR5v3-ContactRoleTypeContactRoleTypeactive2014-03uvhl7tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3210Contact Type (Hepatitis B)active2009-01ussct oid
us.nlm.vsacR42.16.840.1.113883.11.20.9.69.5Advance Directives Content Typesactive2024-04ushl7loinc
acme.dallas.cowboyR4CowboyHatTypesVSCowboyHatTypesVSdraft
hl7.fhir.us.mcodeR4mcode-cytologic-evidence-malignancy-vsCytologic Evidence of Malignancy Value Setactive4cic2025-02ushl7sct icd
hl7.eu.fhir.pcspR4vs-docref-doctype-eu-pcspDocument Typedraft2025-08euhl7internal loinc
hl7.eu.fhir.pcspR4vs-fromToPosteriorAnterior-eu-pcspBody Location Qualifier Value Setdraft2025-08euhl7internal sct
agha.fhir.gencliprR4EncounterTypesEncounter Type Value Setactive2022-03fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.3211Material exposure typeactive2009-01ussct oid
hl7.fhir.us.mcodeR4mcode-hypereosinophilic-syndrome-disorder-vsSpecific Diagnosis of Cancer Value Setactive4cic2025-02ushl7sct icd
us.cdc.phinvadsR42.16.840.1.114222.4.11.7732Infection Type (RIBD)active2018-01ussct tho oid
hl7.fhir.us.davinci-drug-formularyR4InsuranceItemTypeVSInsurance item typetrial-usephx2025-02ushl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.3133Live Birth Outcome (Rubella)active2008-01usoid
us.cdc.phinvadsR42.16.840.1.114222.4.11.1006Type of Long Term Care Facilityactive2019-01ustho oid
hl7.fhir.us.mcodeR4mcode-melanoma-in-situ-disorder-vsMelanoma In-Situ Disorder Value Setactive4cic2025-02ushl7sct icd
tewhatuora.hip-coreR4name-suffixName Suffix Codesactive2024-10national
us.cdc.phinvadsR42.16.840.1.114222.4.11.3135Non-Live Birth Outcome (VPD)active2008-01ussct
uz.dhp.coreR5condition-participation-role-vsTypes of participation roledraft2025-08tho dcm
ca.on.oh.erecR4patient-contact-relationshipPatient Contact Relationshipsdraftcanational
ca.on.oh-cmsR4PatientContactRelationshipsPatientContactRelationshipsdraft
ca.infoway.io.erecR4patient-contact-relationshipPatient Contact Relationshipsdraftnational
hl7.terminologyR5v3-PersonalRelationshipRoleTypePersonalRelationshipRoleTypeactive2014-03uvhl7tho
hl7.terminologyR5v3-PlaceEntityTypePlaceEntityTypeactive2014-03uvhl7tho
hl7.fhir.us.mcodeR4mcode-primary-malignant-neoplasm-disorder-vsPrimary Malignant Neoplasm Disorder Value Setactive4cic2025-02ushl7sct icd
hl7.fhir.us.mcodeR4mcode-primary-cancer-disorder-vsPrimary Cancer Disorder Value Setactive4cic2025-02ushl7fhir
hl7.fhir.us.mcodeR4mcode-cancer-staging-prognostic-factor-type-vsCancer Staging Prognostic Factors Typesactivecic2025-02ushl7sct
dk.ehealth.sundhed.fhir.ig.coreR4ehealth-quality-typesQuality Typesactive2019-02dk
dk.ehealth.sundhed.fhir.ig.coreR4ehealth-questionnaire-elementsQuestionnaire Elementsactive2023-09dk
hl7.eu.fhir.pcspR4vs-radiotherapyDoseType-eu-pcspRadiotherapy Dose Typedraft2025-08euhl7sct dcm
hl7.eu.fhir.pcspR4vs-radiotherapyType-eu-pcspRadiotherapy Typedraft2025-08euhl7sct tho
hl7.terminologyR5goal-relationship-typeGoalRelationshipTypedraftpc2020-02uvhl7tho
hl7.fhir.us.mcodeR4mcode-secondary-cancer-disorder-vsSecondary Cancer Disorder Value Setactive4cic2025-02ushl7sct icd
hl7.fhir.uv.livdR4livd-section-typeTypes of sections for the LIVD catalog VStrial-use2oo2025-07uvhl7fhir
hl7.terminologyR5v3-SecurityPolicySecurityPolicyactive2014-03uvhl7tho
dk.fhir.ig.kl.common.caresocialR4KLServicesTypesKLEncounterTypesactive2020-10
kl.dk.fhir.termR4KLServicesTypesKLServiceTyperactive2024-10dkinternal
kl.dk.fhir.coreR4KLServicesTypesKLServiceTyperactive2023-06dk
uz.dhp.coreR5condition-severity-vsTypes of severitydraft2025-08sct
hl7.eu.fhir.pcspR4vs-shuntProcedureType-eu-pcspShunt Procedure Typedraft2025-08euhl7internal
hl7.terminologyR5software-system-typeSoftware System Typetrial-use3cds2024-02uvhl7tho
hl7.fhir.us.davinci-pasR4PASSupportingInfoTypePAS Supporting Info Type Value Settrial-use3fm2025-07ushl7fhir
hl7.eu.fhir.pcspR4vs-surgicalProcedureType-eu-pcspSurgical Procedure Typedraft2025-08euhl7internal fhir
hl7.eu.fhir.idea4rcR4vs-surgicalProcedureType-eu-i4rcSurgical Procedure Typeactive2025-07euhl7fhir
us.nlm.vsacR42.16.840.1.113883.10.20.22.5.300Transmission Based Precaution Typesactive2024-06ushl7sct
uz.dhp.coreR5condition-verification-status-vsTypes of verification statusdraft2025-08tho
hl7.cda.us.eyecareR5AidToVisionCodesAid to Vision Codesdraft2024-02ushl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7941Job Setting (COVID-19)active2020-01ussct tho
ForgePatientChart.0830R4telus-service-typeTELUS ValueSet - Service Typedraft2020-11hl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.7647Typhoid Paratyphoid Serotype (FDD)active2017-01ussct
us.cdc.phinvadsR42.16.840.1.114222.4.11.3111Typhoid Signs Symptoms (FDD)active2008-01ussct tho oid
de.netzwerk-universitaetsmedizin.ebm-cpgR5vs-rating-preference-and-valuesRating Preference And Valuesdraft2022-09uvhl7internal
hl7.fhir.pl.ssidlR5ssidl-reasonForTestType-VSTypy celu badaniadraft2025-08plhl7internal
hl7.fhir.cz.labR4cz-lab-study-types-VSLaboratory Study Types (CZ)active2022-08czhl7loinc
hl7.fhir.cz.labR4cz-lab-report-types-VSLaboratory Report Types (CZ)draft2025-07czhl7loinc